Crewe Advisors LLC Bluebird Bio, Inc. Transaction History

Crewe Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 05, 2019	SELL	$59.1 - $93.26 $11,820 - $18,652	-200 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$88.86 - $117.49 $2,754 - $3,642	-31 Reduced 13.42%	200 $29,000
Q2 2018 Aug 07, 2018	BUY	$99.64 - $127.59 $597 - $765	6 Added 2.67%	231 $36,000
Q1 2018 May 07, 2018	BUY	$105.8 - $150.94 $2,645 - $3,773	25 Added 12.5%	225 $38,000
Q4 2017 Feb 09, 2018	BUY	$81.25 - $130.7 $16,250 - $26,139	200	200 $36,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Crewe Advisors LLC with notifications on news.